Filing Details
- Accession Number:
- 0001572795-21-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-09 17:46:51
- Reporting Period:
- 2021-01-13
- Accepted Time:
- 2021-02-09 17:46:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1510964 | Cv Sciences Inc. | CVSI | Pharmaceutical Preparations (2834) | 800944970 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1572795 | Jr Joseph Michael Mona | 10070 Barnes Canyon Road San Diego CA 92121 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-01-13 | 100,000 | $0.61 | 1,928,660 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-01-14 | 100,000 | $0.63 | 1,828,660 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-01-15 | 16,600 | $0.66 | 1,812,060 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.60 to $0.62 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.619 to $0.64 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- As of the date of this filing, the reporting person owns a total of 1,986,722 shares of common stock of the issuer, of which, the reporting person indirectly owns 174,662 shares of common stock of the issuer through Aegean Limited LLC, and directly owns 1,812,060 shares of common stock of the issuer.
Billionaire Hedge Funds
